Shares of CannTrust Holdings were on a downturn after the company said this past Friday that it has halted all cannabis sales and shipments while Health Canada reviews its processing plant in Vaughan, Ontario.
The halt voluntary and began at 11:59 p.m. last Wednesday.
“This review is part of a visit that was scheduled by the regulator when CannTrust voluntarily advised Health Canada of issues that may impact compliance at this facility regarding product storage,” said a CannTrust representative.
The representative added, “CannTrust is working closely with the regulator through the review process and expects to provide further detail of the duration of the hold and other developments as they become available.”
The Vaughan plant in Ontario prepares and packages the company’s product portfolio.
